ES2165875T3 - Reduccion de reacciones fisiologicas adversas inducidas por liposomas. - Google Patents
Reduccion de reacciones fisiologicas adversas inducidas por liposomas.Info
- Publication number
- ES2165875T3 ES2165875T3 ES94918106T ES94918106T ES2165875T3 ES 2165875 T3 ES2165875 T3 ES 2165875T3 ES 94918106 T ES94918106 T ES 94918106T ES 94918106 T ES94918106 T ES 94918106T ES 2165875 T3 ES2165875 T3 ES 2165875T3
- Authority
- ES
- Spain
- Prior art keywords
- adverse physiological
- liposomes
- reduction
- liposome
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE SUMINISTRA UN METODO PARA SUMINISTRAR UNA COMPOSICION LIPOSOMAS A UN ANIMAL. EL METODO COMPRENDE LA ADMINISTRACION AL ANIMAL DE UNA COMPOSICION DE LIPOSOMAS QUE CONTENGA UNA CANTIDAD EFECTIVA REDUCTORA DE LA REACCION, FISIOLOGICA, ADVERSA DE UN LIPOSOMA QUE TIENE, ADEMAS DEL AGENTE BIOACTIVO, UNA BICAPA DE LIPIDO QUE CONTIENE UN LIPIDO Y UNA MOLECULA MODIFICADA POR UN AGENTE SUPERFICIAL. LA REACCION FISIOLOGICA ADVERSA QUE PUEDE SER EXPERIMENTADA POR EL ANIMAL DESPUES DE LA ADMINISTRACION DE UNA COMPOSICION DE LIPOSOMAS SE REDUCE POR MEDIO DE LA PRESENCIA DE LA MOLECULA MODIFICADA POR EL AGENTE SUPERFICIAL EN LA BICAPA DE LIPIDO DEL LIPOSOMA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6592893A | 1993-05-21 | 1993-05-21 | |
US20765194A | 1994-03-07 | 1994-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2165875T3 true ES2165875T3 (es) | 2002-04-01 |
Family
ID=26746185
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94918106T Expired - Lifetime ES2165875T3 (es) | 1993-05-21 | 1994-05-20 | Reduccion de reacciones fisiologicas adversas inducidas por liposomas. |
ES01100692T Pending ES2193005T1 (es) | 1993-05-21 | 1994-05-20 | Reduccion de reacciones fisiologicas adversas inducidas por liposomas. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES01100692T Pending ES2193005T1 (es) | 1993-05-21 | 1994-05-20 | Reduccion de reacciones fisiologicas adversas inducidas por liposomas. |
Country Status (15)
Country | Link |
---|---|
US (2) | US5614214A (es) |
EP (2) | EP1118326A3 (es) |
JP (1) | JPH08510748A (es) |
KR (1) | KR960702297A (es) |
AT (1) | ATE210966T1 (es) |
AU (1) | AU680513B2 (es) |
CA (1) | CA2160118A1 (es) |
DE (2) | DE1118326T1 (es) |
DK (1) | DK0699068T3 (es) |
ES (2) | ES2165875T3 (es) |
GR (1) | GR20010300075T1 (es) |
NO (1) | NO954691D0 (es) |
NZ (1) | NZ267310A (es) |
PT (1) | PT699068E (es) |
WO (1) | WO1994027580A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ128096A3 (en) * | 1993-11-04 | 1997-08-13 | Schering Ag | Charged liposome preparation |
US5885613A (en) * | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
US5820873A (en) * | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
PT785773E (pt) * | 1994-10-14 | 2001-05-31 | Liposome Co Inc | Lipossomas de eteres lipidicos e sua utilizacao terapeutica |
US6673364B1 (en) | 1995-06-07 | 2004-01-06 | The University Of British Columbia | Liposome having an exchangeable component |
US5965159A (en) | 1996-02-16 | 1999-10-12 | The Liposome Company, Inc. | Etherlipid-containing multiple lipid liposomes |
US6007839A (en) * | 1996-02-16 | 1999-12-28 | The Liposome Company, Inc. | Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes |
US5942246A (en) * | 1996-02-16 | 1999-08-24 | The Liposome Company, Inc. | Etherlipid containing multiple lipid liposomes |
US6667053B1 (en) | 1996-02-16 | 2003-12-23 | Elan Pharmaceuticals, Inc. | D and L etherlipid stereoisomers and liposomes |
USRE39042E1 (en) * | 1996-02-16 | 2006-03-28 | The Liposome Company, Inc. | Etherlipid-containing multiple lipid liposomes |
US20030199425A1 (en) * | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
US6734171B1 (en) | 1997-10-10 | 2004-05-11 | Inex Pharmaceuticals Corp. | Methods for encapsulating nucleic acids in lipid bilayers |
EP0976394A1 (en) * | 1998-07-30 | 2000-02-02 | Biosearch Italia S.p.A. | New injectable formulations |
US6593308B2 (en) * | 1999-12-03 | 2003-07-15 | The Regents Of The University Of California | Targeted drug delivery with a hyaluronan ligand |
ES2332584T3 (es) * | 2001-03-27 | 2010-02-09 | Phares Pharmaceutical Research N.V. | Metodo y composicion para solubilizar un compuesto biologicamente activo con baja solubilidad en agua. |
JP2005525992A (ja) * | 2001-06-25 | 2005-09-02 | イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム | 生物学的物質を充填した小胞の調製法およびそれらの様々な使用 |
US20030180348A1 (en) * | 2002-03-22 | 2003-09-25 | Levinson R. Saul | Transcellular drug delivery system |
US6811777B2 (en) | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US7462703B2 (en) * | 2003-01-31 | 2008-12-09 | Max-Delbruck-Centrum Fur Molekulare Medizin | Agent for gene transfer |
CN1319520C (zh) * | 2005-02-03 | 2007-06-06 | 上海交通大学 | 核苷膦酸类化合物的脂质体和脂质复合物制剂 |
US8080262B2 (en) * | 2006-10-24 | 2011-12-20 | Northwestern University | Encapsulated peptide amphiphile nanostructures |
US20100112081A1 (en) | 2008-10-07 | 2010-05-06 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
EP2486923B1 (en) * | 2011-02-11 | 2015-09-09 | Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG | Histone deacetylase (HDAC) inhibiting compounds and method of making same |
US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
US20210154307A1 (en) * | 2019-11-07 | 2021-05-27 | Northeastern University | Cationic nanostructures for intra-cartilage delivery of therapeutics and contrast agents |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3577446A (en) * | 1968-09-09 | 1971-05-04 | American Home Prod | Phosphatidylalkanolamine derivatives |
US3993754A (en) * | 1974-10-09 | 1976-11-23 | The United States Of America As Represented By The United States Energy Research And Development Administration | Liposome-encapsulated actinomycin for cancer chemotherapy |
US4086257A (en) * | 1976-10-12 | 1978-04-25 | Sears Barry D | Phosphatidyl quaternary ammonium compounds |
CH621479A5 (es) * | 1977-08-05 | 1981-02-13 | Battelle Memorial Institute | |
CH624011A5 (es) * | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4522803A (en) * | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
US4588578A (en) * | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
US5030453A (en) * | 1983-03-24 | 1991-07-09 | The Liposome Company, Inc. | Stable plurilamellar vesicles |
EP0153955A1 (en) * | 1983-09-06 | 1985-09-11 | Health Research, Inc. | Liposome delivery method for decreasing the toxicity of an antitumor drug |
US4721612A (en) * | 1984-04-12 | 1988-01-26 | The Liposome Company, Inc. | Steroidal liposomes |
US5008050A (en) * | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
CA1264668A (en) * | 1984-06-20 | 1990-01-23 | Pieter R. Cullis | Extrusion techniques for producing liposomes |
CA1270198A (en) * | 1984-08-08 | 1990-06-12 | Marcel B. Bally | Encapsulation of antineoplastic agents in liposomes |
US5077056A (en) * | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
JPS6188887A (ja) * | 1984-10-08 | 1986-05-07 | Meito Sangyo Kk | 酵素法1−o−アルキル−2−アシルグリセロリン脂質誘導体の製法 |
US4975282A (en) * | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
JP2579625B2 (ja) * | 1985-07-05 | 1997-02-05 | ザ リポソ−ム カンパニ−,インコ−ポレイテツド | 改良された取り込み効率を有するマルチラメラリポソ−ム |
PH26160A (en) * | 1985-08-19 | 1992-03-18 | Univ Texas | Pharmaceutical compositions consisting of acylated phospholipids |
US4861580A (en) * | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
US5041278A (en) * | 1985-10-15 | 1991-08-20 | The Liposome Company, Inc. | Alpha tocopherol-based vesicles |
NZ223660A (en) * | 1987-03-05 | 1990-11-27 | Liposome Co Inc | Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity |
CH672733A5 (es) * | 1987-05-22 | 1989-12-29 | Bracco Ind Chimica Spa | |
US5080833A (en) * | 1987-09-21 | 1992-01-14 | Kabushiki Kaisha Toshiba | Immobilization of bioactive substance on lipid composition containing modified lipid compound |
JPH04505616A (ja) * | 1989-05-15 | 1992-10-01 | ザ リポソーム カンパニー,インコーポレイテッド | プロトン勾配によるリポソームへの薬剤の蓄積 |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
DE69108254T2 (de) * | 1990-10-09 | 1995-10-19 | Vestar Inc | Vesikel aus phospholipidderivaten mit einem succinimidylsubstituenten. |
US5313804A (en) * | 1993-04-23 | 1994-05-24 | Maritime Geothermal Ltd. | Direct expansion geothermal heat pump |
-
1994
- 1994-05-20 DE DE1118326T patent/DE1118326T1/de active Pending
- 1994-05-20 DE DE69429511T patent/DE69429511T2/de not_active Expired - Fee Related
- 1994-05-20 EP EP01100692A patent/EP1118326A3/en not_active Withdrawn
- 1994-05-20 CA CA002160118A patent/CA2160118A1/en not_active Abandoned
- 1994-05-20 DK DK94918106T patent/DK0699068T3/da active
- 1994-05-20 NZ NZ267310A patent/NZ267310A/en unknown
- 1994-05-20 JP JP7500895A patent/JPH08510748A/ja not_active Withdrawn
- 1994-05-20 WO PCT/US1994/005824 patent/WO1994027580A1/en active IP Right Grant
- 1994-05-20 ES ES94918106T patent/ES2165875T3/es not_active Expired - Lifetime
- 1994-05-20 KR KR1019950705072A patent/KR960702297A/ko not_active Application Discontinuation
- 1994-05-20 PT PT94918106T patent/PT699068E/pt unknown
- 1994-05-20 US US08/247,053 patent/US5614214A/en not_active Expired - Lifetime
- 1994-05-20 ES ES01100692T patent/ES2193005T1/es active Pending
- 1994-05-20 EP EP94918106A patent/EP0699068B1/en not_active Expired - Lifetime
- 1994-05-20 AU AU69568/94A patent/AU680513B2/en not_active Ceased
- 1994-05-20 AT AT94918106T patent/ATE210966T1/de not_active IP Right Cessation
-
1995
- 1995-05-04 US US08/433,665 patent/US5662930A/en not_active Expired - Lifetime
- 1995-11-20 NO NO954691A patent/NO954691D0/no not_active Application Discontinuation
-
2001
- 2001-12-31 GR GR20010300075T patent/GR20010300075T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0699068T3 (da) | 2002-03-11 |
NO954691L (no) | 1995-11-20 |
EP0699068A1 (en) | 1996-03-06 |
EP1118326A2 (en) | 2001-07-25 |
US5662930A (en) | 1997-09-02 |
DE1118326T1 (de) | 2002-04-18 |
GR20010300075T1 (en) | 2001-12-31 |
CA2160118A1 (en) | 1994-12-08 |
DE69429511T2 (de) | 2002-05-16 |
NZ267310A (en) | 1996-09-25 |
EP1118326A3 (en) | 2002-07-31 |
US5614214A (en) | 1997-03-25 |
AU680513B2 (en) | 1997-07-31 |
ES2193005T1 (es) | 2003-11-01 |
WO1994027580A1 (en) | 1994-12-08 |
DE69429511D1 (de) | 2002-01-31 |
PT699068E (pt) | 2002-06-28 |
ATE210966T1 (de) | 2002-01-15 |
AU6956894A (en) | 1994-12-20 |
EP0699068B1 (en) | 2001-12-19 |
NO954691D0 (no) | 1995-11-20 |
KR960702297A (ko) | 1996-04-27 |
JPH08510748A (ja) | 1996-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2165875T3 (es) | Reduccion de reacciones fisiologicas adversas inducidas por liposomas. | |
HU9403823D0 (en) | Moisturizing composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof | |
EP0251717A3 (en) | Chemically modified islet-activating protein | |
FI891592A0 (fi) | Hudvaordskomposition och foerfarande foer dess framstaellning. | |
NL300382I1 (nl) | Treatment of pompe's disease | |
EP0430045A3 (en) | Ascorbic acid tocopheryl phosphate diesters for inhibition of maillard's reaction | |
GR3005442T3 (es) | ||
AU4299689A (en) | Biologicaly active lipoprotein and its use | |
DE69332276D1 (de) | Liposomenzusammensetzung | |
BG104470A (en) | The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases | |
FR2623716B1 (fr) | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant | |
AU8132587A (en) | Penetration enhancers for transdermal delivery of systemic agents | |
EP0642338A1 (en) | USE OF (E) - 2 - (P -FLUOROPHENETHYL) - 3 - FLUOROALLYLAMINE FOR TREATING ALZHEIMER'S DISEASE. | |
DK0575974T3 (es) | ||
CA2170289A1 (en) | A method of treating liver disease and like indications with vasodilating agents | |
FR2579463B1 (fr) | Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne | |
IT8648228A0 (it) | Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestetici generali alogenati | |
IT8647570A0 (it) | Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne giovanile | |
IT1281262B1 (it) | Siringa per l'iniezione di grandi quantita' di liquido, come liquido disinfettante, conservativo, medicinale o simili |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 699068 Country of ref document: ES |